购物车
- 全部删除
- 您的购物车当前为空
FTIDC 是非竞争性和选择性的口服变构代谢型谷氨酸受体 1 拮抗剂,对人 mGluR1a 的IC50为 5.8 nM。
为众多的药物研发团队赋能,
让新药发现更简单!
FTIDC 是非竞争性和选择性的口服变构代谢型谷氨酸受体 1 拮抗剂,对人 mGluR1a 的IC50为 5.8 nM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 917 | 现货 | |
2 mg | ¥ 1,370 | 现货 | |
5 mg | ¥ 2,360 | 现货 | |
10 mg | ¥ 3,770 | 现货 | |
25 mg | ¥ 5,930 | 现货 | |
50 mg | ¥ 8,190 | 现货 | |
100 mg | ¥ 10,800 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 2,530 | 现货 |
产品描述 | FTIDC is a highly potent and selective allosteric antagonist of mGluR1 receptors and shows very weak potency against human and rat mGluR5 receptors. The inhibition of FTIDC for mGluR1 receptors is shown to be in noncompetitive manner and displays IC50 values of 5.8 and 3.1 nM for human and mouse mGluR1 expressed in CHO cells respectively. |
靶点活性 | mGluR1(human):5.8 nM, mGluR1(mouse):3.1 nM |
分子量 | 358.41 |
分子式 | C18H23FN6O |
CAS No. | 873551-53-2 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 35.8 mg/mL (100 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.